- Current report filing (8-K)
25 June 2009 - 2:37AM
Edgar (US Regulatory)
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of Earliest Event Reported): June 23, 2009
PARADIGM
MEDICAL INDUSTRIES, INC.
(Exact
name of registrant as specified in this Charter)
Delaware
|
0-28498
|
87-0459536
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
2355 South 1070 West, Salt Lake City, Utah
|
84119
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
Telephone Number, Including Area Code:
(801)
977-8970
Does Not Apply
(Former
name or former address, if changed since last report)
Section
8.01. Termination of Letter of Intent and Business Relationship with
Fairhills Capital Offshore, LLC
On April
6, 2009, Paradigm Medical Industries, Inc. ("Paradigm") signed a Letter of
Intent with Fairhills Capital Offshore, LLC ("Fairhills Capital") for a
structured financing of up to $1.8 million through the purchase of promissory
notes from Paradigm. The Letter of Intent provided that $600,000 in
notes would be purchased every three months over a nine month period with
$300,000 in notes to be purchased at closing and the remainder to be purchased
upon the satisfaction of financial objectives to be mutually determined between
Paradigm and Fairhills Capital. Fairhills Capital is represented in
the transaction by Edward Bronson, its managing partner.
Definitive
documents, dated May 4, 2009, were prepared by counsel for Fairhills Capital in
connection with the transaction. Despite representations by Mr.
Bronson that initial funding would be made to Paradigm, Paradigm has not yet
received any funds from Fairhills Capital. On June 22, 2009, the
Board of Directors of Paradigm notified Mr. Bronson that Fairhills Capital had
until the end of business on June 23, 2009 to provide the initial
funding. Because no funding was received by the deadline, the Board
of Directors of Paradigm notified Mr. Bronson and Fairhills Capital of the
termination of the Letter of Intent and the business relationship between
Paradigm and Fairhills Capital.
Paradigm
is currently involved in discussions with other prospective investors in an
effort to obtain additional funding, but there can be no assurance that Paradigm
will be successful in obtaining any additional funding.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
PARADIGM
MEDICAL INDUSTRIES, INC.
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
June 24, 2009
|
By:
|
/s/
Stephen L.
Davis
|
|
|
Stephen
L. Davis, President and
|
|
|
Chief
Executive Officer
|
Paradigm Medical Industr... (CE) (USOTC:PDMI)
Historical Stock Chart
From Jan 2025 to Feb 2025
Paradigm Medical Industr... (CE) (USOTC:PDMI)
Historical Stock Chart
From Feb 2024 to Feb 2025